Stay updated on IRX-2 Regimen and Durvalumab Clinical Trial

Sign up to get notified when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2 Regimen and Durvalumab Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov page footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T13:59:39.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-12T14:43:55.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 has been added to the study record history, indicating an updated submission. The previous revision v3.6.6 was removed from the visible history.
    Difference
    0.1%
    Check dated 2026-09-21T22:09:23.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new revision entry, Revision: v3.6.6, was added to the record history. The previous Revision: v3.6.5 entry was removed.
    Difference
    0.1%
    Check dated 2026-08-31T17:10:54.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    No additions or deletions are reported in the page history for this study record. Therefore, there are no changes to interpret in this evaluation.
    Difference
    0.1%
    Check dated 2026-08-24T16:49:47.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    There are no textual additions or deletions in the provided data for the page history. The study history content remains unchanged in terms of text.
    Difference
    0.1%
    Check dated 2026-08-17T13:47:50.000Z thumbnail image

Stay in the know with updates to IRX-2 Regimen and Durvalumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen and Durvalumab Clinical Trial page.